Creo Medical Group plc Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Kevin T. Crofton, was filed 02 Jun 2025.
Creo Medical Group plc: what insiders have been doing
This page follows insider dealings at Creo Medical Group plc as filed with RNS (LSE), a company from the Health Care sector. Creo Medical Group plc has had no insider filing for more than a year; the last one goes back to 2 June 2025.
The full history, which starts in 2017, counts 16 purchases against 4 sales.
These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -41.2%Entry £0.17 · Close at T+365 £0.10
- -44.4%Entry £0.20 · Close at T+365 £0.11
- -44.4%Entry £0.20 · Close at T+365 £0.11
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 0London Stock ExchangeRNS:5676524Canonical exit: 28 Aug 2025 (T+90)
- 0London Stock ExchangeRNS:5469401Canonical exit: 13 Mar 2025 (T+90)
- 0London Stock ExchangeRNS:5402721-0
- 0London Stock ExchangeRNS:5402721-1Canonical exit: 22 Jan 2025 (T+90)
- 0London Stock ExchangeRNS:5402721-2Canonical exit: 22 Jan 2025 (T+90)
- 0London Stock ExchangeRNS:5402651-0
- 0London Stock ExchangeRNS:5402651-1Canonical exit: 22 Jan 2025 (T+90)
- 0London Stock ExchangeRNS:5402651-2Canonical exit: 22 Jan 2025 (T+90)
- 15,435 shares@ £0.971815.4% of flowLondon Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:4385348-0Canonical exit: 24 Aug 2022 (T+90)
- 70,000 shares@ £0.9675100.0% of flowLondon Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:4385348-1Canonical exit: 24 Aug 2022 (T+90)
- 9,657 shares@ £1.82517.9% of flowLondon Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:4105227Canonical exit: 6 Dec 2021 (T+90)
- 24,509 shares@ £2.04100.0% of flowLondon Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:3666683Canonical exit: 22 Oct 2020 (T+90)
- 14,220 shares@ £1.406428.3% of flowLondon Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:LSE20190807135753_14180319_20200326185058613_33556Canonical exit: 4 Nov 2019 (T+90)
- 336,000 shares@ £0.1556100.0% of flowLondon Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:LSE20181123104356_13878591_20200330111438130_7702
- 480,000 shares@ £1.25100.0% of flowLondon Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:LSE20180831113008_13774848_20200330111400472_427-0
- 480,000 shares@ £1.25100.0% of flowLondon Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:LSE20180831113008_13774848_20200330111400472_427-1
- 480,000 sharesOff MarketISIN GB00BZ1BLL44FCA-NSM:LSE20180820101344_13761231_20200330111401385_9446-0Canonical exit: 15 Nov 2018 (T+90)
- 480,000 sharesOff MarketISIN GB00BZ1BLL44FCA-NSM:LSE20180820101344_13761231_20200330111401385_9446-1Canonical exit: 13 Nov 2018 (T+90)
- 230,325 shares@ £0.6869.2% of flowLondon Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:LSE20180109174319_13490681_20200330111417429_20407Canonical exit: 9 Apr 2018 (T+90)
- 115,000 shares@ £0.15567.9% of flowOff MarketISIN GB00BZ1BLL44FCA-NSM:LSE20171222121027_13476278_20200330131510628_19125
- 73,380 shares@ £0.6957.9% of flowLondon Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:LSE20171222092429_13475778_20200330131510596_18780Canonical exit: 21 Mar 2018 (T+90)
- 208,028 shares@ £0.93525.3% of flowLondon Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:LSE20170202072156_13115252_20200330131513511_637Canonical exit: 1 May 2017 (T+90)
22 of 22 declarations
About Creo Medical Group plc
Creo Medical Group plc is a company focused on developing innovative medical technologies for cancer treatment. It aims to create devices that enhance patient outcomes through less invasive approaches.
